Trials / Completed
CompletedNCT02018445
Accell Evo3™ Demineralized Bone Matrix in Instrumented Lumbar Spine Fusion
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- SeaSpine, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to prospectively evaluate the performance of Integra Accell Evo3 Demineralized Bone Matrix as an adjunct for instrumented posterolateral spine fusion, as compared to local autograft.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Posterolateral Fusion |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2015-07-01
- Completion
- 2017-05-01
- First posted
- 2013-12-23
- Last updated
- 2020-02-18
- Results posted
- 2020-02-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02018445. Inclusion in this directory is not an endorsement.